Ibrexafungerp (ibrexafungerp)

Approved for 1 INDICATIONS AND USAGE BREXAFEMME is a triterpenoid antifungal indicated in adult and post-menarchal pediatric females for: Treatment of vulvovaginal candidiasis (VVC). ( 1.1 ) Reduction in the incidence of recurrent vulvovaginal candidiasis (RVVC) ( 1.1 ) 1.1 Vulvovaginal Candidiasis BREXAFEMME ® is indicated in adult and post-menarchal pediatric females for: ● Treatment of…

Loading full data from Know Your Drugs Institute…